APA

Tsareva E. I., Kulakova O. G., Makarycheva O. I., Boĭko A. N., Shchur S. G., Lashch N. I., Popova N. F., Gusev E. I., Bashinskaia V. V., L'vov D. V., Favorov A. V., Ochs M. F. & Favorova O. O. (20120302). [Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. : Molekuliarnaia biologiia.

Chicago

Tsareva E Iu, Kulakova O G, Makarycheva O Iu, Boĭko A N, Shchur S G, Lashch N Iu, Popova N F, Gusev E I, Bashinskaia V V, L'vov D V, Favorov A V, Ochs M F and Favorova O O. 20120302. [Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. : Molekuliarnaia biologiia.

Harvard

Tsareva E. I., Kulakova O. G., Makarycheva O. I., Boĭko A. N., Shchur S. G., Lashch N. I., Popova N. F., Gusev E. I., Bashinskaia V. V., L'vov D. V., Favorov A. V., Ochs M. F. and Favorova O. O. (20120302). [Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. : Molekuliarnaia biologiia.

MLA

Tsareva E Iu, Kulakova O G, Makarycheva O Iu, Boĭko A N, Shchur S G, Lashch N Iu, Popova N F, Gusev E I, Bashinskaia V V, L'vov D V, Favorov A V, Ochs M F and Favorova O O. [Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. : Molekuliarnaia biologiia. 20120302.